Archives

by in
Entry Author Date Location
Immune Design Rakes In Another $11M From Prior VC Round 10/05/11 Seattle
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
Presage Adds $1.5M 08/10/11 Seattle
How Seattle Set Out to Create a Biotech Hub and Fostered a Global Health Nexus 08/08/11 Seattle
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Hutch, Sangamo Win $20M HIV Grant 07/11/11 Seattle
ASCO Wrap-Up, Pathway Medical Grinds It Out, Gates Foundation’s New Digs, & More in Seattle-Area Life Sciences News 06/09/11 Seattle
Adaptive TCR, a Fred Hutch Spinoff, Snags $5.8M to Take Immune System Profiling Up a Notch 06/06/11 Seattle
Finding a Solution To Our Biotech Malaise Together 05/18/11 Seattle
Bill Gates’ Favorite Biofuel Company on the Docket for Thursday’s Alternative Fuels Event 05/16/11 Seattle
Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News 05/12/11 Seattle
Matrix Genetics Pursues the Algae Fuel Dream in the Lab, Not With Big Steel Tanks, Giant Ponds 05/12/11 Seattle
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up 03/04/11 Seattle
Washington’s Innovation Corridor a Key to Recovery 02/18/11 Seattle
Top Trends to Watch in 2011 From Experts in Infotech, Biotech, Cleantech 01/19/11 National
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News 01/06/11 Seattle
Hutch Buys Building for $36M 12/17/10 Seattle
Adaptive TCR Seeks to Dominate New Industry, Ultrasound on an iPhone, AVI Names CEO, & More Seattle-Area Life Sciences News 12/16/10 Seattle
Adaptive TCR Seeks to Dominate New Industry in Profiling The Immune System 12/13/10 Seattle
Hutch Snaps Up $5.6M at Holiday Gala 12/08/10 Seattle
Sequenta Pockets $13M To Diagnose, Monitor Immune Systems Going Awry 12/08/10 San Francisco
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO 11/12/10 Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News 11/11/10 Seattle
Report: Ikaria Withdraws IPO, Leaving Arch, Hutch in the Lurch 11/10/10 Seattle
Ikaria IPO Finds So-So Demand, Company Slashes Proposed Offering 38 Percent 11/10/10 Seattle
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan 11/10/10 Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech 11/09/10 Seattle
Steve Davis, the Techie Turned Global Healthie, Gets Dose of Reality at Close Range in India 11/05/10 Seattle
Dendreon’s Plan to Meet Demand, Arch Banks on Ikaria IPO, RF Surgical Leaves No Sponge Behind, & More Seattle-Area Life Sciences News 11/04/10 Seattle
Arch, Hutch Stand to Gain From “Hibernation on Demand” Through Ikaria IPO 11/02/10 Seattle
Page 2 of 6 « previous page · next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.